Gov't Shutdown Delays Merck's FDA Drug Hearing
In apparent fallout from the government shutdown, drugmakers Merck & Co. Inc. and Stallergenes on Tuesday announced that the U.S. Food and Drug Administration has postponed advisory committee meetings to discuss...To view the full article, register now.
Already a subscriber? Click here to view full article